a developer of peptide, peptide mimetic and small molecule agonist compounds
Industry Biotechnology
A.I.dvisor tells us that PTN and KRYS have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTN and KRYS's prices will move in lockstep.
Ticker / NAME | Correlation To PTN | 1D Price Change % | ||
---|---|---|---|---|
PTN | 100% | -9.64% | ||
KRYS - PTN | 32% Poorly correlated | -7.34% | ||
DNLI - PTN | 30% Poorly correlated | -7.71% | ||
IMNM - PTN | 27% Poorly correlated | -7.57% | ||
PGEN - PTN | 27% Poorly correlated | +3.26% | ||
ATXS - PTN | 26% Poorly correlated | -1.99% | ||
More |